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Plants are a rich source of unique molecules, including 25% of natural-product-derived drugs. However, the 
discovery, synthesis, and overall material supply chains for sourcing plant-based medicines remain ad hoc, 
biased, and tedious. While microbial biosynthesis presents compelling alternatives to traditional approaches 
based on extraction from natural plant hosts, many challenges exist in the reconstruction of plant specialized 
metabolic pathways in microbial hosts. We have developed approaches to address the challenges that arise in 
the reconstruction of complex plant biosynthetic pathways in microbial hosts. We have utilized these strategies 
to develop yeast production platforms for an important class of plant alkaloids, which include the medicinal 
opioids and noscapinoids. The intersection of synthetic biology, genomics, and informatics will lead to 
transformative advances in how we make and discover essential medicines.  
 
